Glenmede Trust CO Na Astrazeneca PLC Transaction History

Glenmede Trust CO Na

  • $19.1 Billion
  • Q4 2024

A detailed history of Glenmede Trust CO Na transactions in Astrazeneca PLC stock. As of the latest transaction made, Glenmede Trust CO Na holds 125,755 shares of AZN stock, worth $9.48 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
125,755
Previous 191,132 34.21%
Holding current value
$9.48 Million
Previous $14.9 Million 44.68%
% of portfolio
0.04%
Previous 0.07%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
SELL
$63.2 - $79.58 $4.13 Million - $5.2 Million
-65,377 Reduced 34.21%
125,755 $8.24 Million
Q3 2024

Nov 13, 2024
BUY
$76.67 - $87.62 $521,969 - $596,516
6,808 Added 3.69%
191,132 $14.9 Million
Q2 2024

Aug 14, 2024
SELL
$66.81 - $80.83 $373,000 - $451,273
-5,583 Reduced 2.94%
184,324 $14.4 Million
Q1 2024

May 15, 2024
SELL
$61.03 - $69.57 $903,060 - $1.03 Million
-14,797 Reduced 7.23%
189,907 $12.9 Million
Q4 2023

Feb 13, 2024
SELL
$61.89 - $69.28 $13,430 - $15,033
-217 Reduced 0.11%
204,704 $13.8 Million
Q3 2023

Nov 14, 2023
SELL
$64.85 - $71.7 $2.88 Million - $3.18 Million
-44,396 Reduced 17.81%
204,921 $13.9 Million
Q1 2023

May 15, 2023
BUY
$63.15 - $71.6 $543,153 - $615,831
8,601 Added 3.57%
249,317 $17.3 Million
Q4 2022

Feb 14, 2023
BUY
$54.21 - $70.44 $630,733 - $819,569
11,635 Added 5.08%
240,716 $16.3 Million
Q3 2022

Nov 16, 2022
BUY
$53.02 - $135.75 $1.1 Million - $2.81 Million
20,717 Added 9.94%
229,081 $12.6 Million
Q2 2022

Aug 15, 2022
BUY
$59.26 - $71.14 $1.18 Million - $1.41 Million
19,889 Added 10.55%
208,364 $13.8 Million
Q1 2022

May 16, 2022
BUY
$55.72 - $67.12 $291,248 - $350,836
5,227 Added 2.85%
188,475 $12.5 Million
Q4 2021

Feb 15, 2022
SELL
$54.02 - $63.83 $732,997 - $866,109
-13,569 Reduced 6.89%
183,248 $10.7 Million
Q3 2021

Nov 15, 2021
BUY
$55.56 - $60.79 $813,009 - $889,540
14,633 Added 8.03%
196,817 $11.8 Million
Q2 2021

Aug 16, 2021
SELL
$48.42 - $60.18 $875,627 - $1.09 Million
-18,084 Reduced 9.03%
182,184 $10.9 Million
Q1 2021

May 18, 2021
BUY
$47.16 - $54.44 $2.74 Million - $3.16 Million
58,078 Added 40.85%
200,268 $9.96 Million
Q4 2020

Feb 16, 2021
BUY
$48.52 - $58.02 $232,459 - $277,973
4,791 Added 3.49%
142,190 $7.11 Million
Q3 2020

Nov 16, 2020
BUY
$53.07 - $61.1 $83,160 - $95,743
1,567 Added 1.15%
137,399 $7.53 Million
Q2 2020

Aug 14, 2020
SELL
$43.1 - $55.31 $783,213 - $1.01 Million
-18,172 Reduced 11.8%
135,832 $7.18 Million
Q4 2019

Feb 12, 2020
BUY
$42.46 - $50.46 $37,407 - $44,455
881 Added 0.58%
154,004 $7.68 Million
Q3 2019

Nov 14, 2019
SELL
$40.12 - $45.47 $382,664 - $433,692
-9,538 Reduced 5.86%
153,123 $6.82 Million
Q2 2019

Aug 13, 2019
SELL
$37.28 - $41.68 $91,112 - $101,865
-2,444 Reduced 1.48%
162,661 $6.71 Million
Q1 2019

May 14, 2019
SELL
$35.49 - $43.02 $347,695 - $421,466
-9,797 Reduced 5.6%
165,105 $6.67 Million
Q4 2018

Feb 14, 2019
SELL
$36.86 - $41.49 $1.45 Million - $1.63 Million
-39,221 Reduced 18.32%
174,902 $6.64 Million
Q3 2018

Nov 15, 2018
SELL
$34.76 - $39.72 $158,192 - $180,765
-4,551 Reduced 2.08%
214,123 $8.47 Million
Q2 2018

Aug 15, 2018
SELL
$34.55 - $37.05 $6.7 Million - $7.18 Million
-193,780 Reduced 46.98%
218,674 $7.68 Million
Q4 2017

Feb 15, 2018
BUY
$32.09 - $34.78 $2.34 Million - $2.54 Million
73,035 Added 21.52%
412,454 $14.3 Million
Q3 2017

Nov 14, 2017
BUY
$28.96 - $34.0 $9.83 Million - $11.5 Million
339,419
339,419 $0

Others Institutions Holding AZN

# of Institutions
1,358
Shares Held
512M
Call Options Held
6.08M
Put Options Held
4.44M
View Full List

About ASTRAZENECA PLC

AZN Quotes by TradingView
  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $234B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Glenmede Trust CO Na Portfolio

Follow Glenmede Trust CO Na and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Glenmede Trust CO Na, based on Form 13F filings with the SEC.

News

Stay updated on Glenmede Trust CO Na with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email